Assessment of Hematological Biomarkers, Including Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios, in Diabetic Nephropathy for Patients with Type 2 Diabetes

Neutrophil-Lymphocyte Ratio as A predictor Inflammatory Marker for Microvascular Complications of Type 2 Diabetes

Study of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) as a predictor inflammatory marker for diabetic nephropathy in type 2 diabetic patients

Neutrophil-Lymphocyte and Platelet-Lymphocyte ratios as a marker for diabetes control and complications.

Comparative Study of Some Parameters in The Diagnosis of Diabetic Nephropathy

Neutrophil-to-Lymphocyte Ratio as a Novel Marker for Early Detection of Hypertensive Nephropathy and as a Predictor of Worsening Renal Functions in Hypertensive Patients

Tissue inhibitor metalloproteinase-1, Plasminogen activator inhibitor 1, and neutrophil/lymphocyte ratio as potential early biomarkers for diabetic nephropathy

The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Evaluation of Inflammation and Nutritional Status in Chronic Kidney Disease Patients

The Benefit of Neutrophil to Lymphocyte Ratio vs Platelet to Lymphocyte Ratio as New Indicators of Erythropoietin Resistance in Patients Receiving Hemodialysis